Rocklatan Eye Drops Dosage
Generic name: NETARSUDIL MESYLATE 0.20mg in 1mL, Latanoprost 0.05mg in 1mL
Dosage form: ophthalmic solution
Drug class: Ophthalmic glaucoma agents
Medically reviewed by Drugs.com. Last updated on Mar 19, 2025.
The recommended dosage is one drop in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose in the evening. The dosage of ROCKLATAN should not exceed once daily.
ROCKLATAN may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.
More about Rocklatan (latanoprost / netarsudil ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (23)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Xalatan
Xalatan (latanoprost) is used to treat certain types of glaucoma. Includes Xalatan side effects ...
Lumigan
Lumigan is used to treat open angle glaucoma. Learn about side effects, interactions and indications.
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Cosopt
Cosopt reduces the amount of fluid in the eye and is used to treat glaucoma. Learn about side ...
Combigan
Combigan (brimonidine and timolol) is used to treat glaucoma or ocular hypertension. Includes ...
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Bimatoprost ophthalmic
Bimatoprost ophthalmic is used for glaucoma, open angle, intraocular hypertension
Dorzolamide ophthalmic
Dorzolamide ophthalmic is used for glaucoma, open angle, intraocular hypertension
Brimonidine ophthalmic
Brimonidine ophthalmic is used for eye redness, glaucoma, open angle, intraocular hypertension
Timolol ophthalmic
Timolol ophthalmic is used for glaucoma, open angle, intraocular hypertension
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.